Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

TDOC

Teladoc Health Inc

Sep 20 • 04:00PM ET

8.75

Dollar change -0.43
Percentage change -4.68	%

Healthcare • Health Information Services • USA • NYSE

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: IWM VTI VB VXF VBK IWN SCHA FDN VTWO SCHM

Index	RUT	P/E	-	EPS (ttm)	-5.93	Insider Own	1.54%	Shs Outstand	171.22M	Perf Week	8.16%
Market Cap	1.50B	Forward P/E	-	EPS next Y	-0.87	Insider Trans	-5.10%	Shs Float	168.58M	Perf Month	18.56%
Income	-1005.52M	PEG	-	EPS next Q	-0.27	Inst Own	80.79%	Short Float	16.00%	Perf Quarter	-9.89%
Sales	2.61B	P/S	0.57	EPS this Y	-334.55%	Inst Trans	-2.97%	Short Ratio	3.88	Perf Half Y	-42.74%
Book/sh	8.78	P/B	1.00	EPS next Y	85.08%	ROA	-25.65%	Short Interest	26.97M	Perf Year	-57.32%
Cash/sh	6.79	P/C	1.29	EPS next 5Y	-	ROE	-52.96%	52W Range	6.76 - 22.54	Perf YTD	-59.40%
Dividend Est.	-	P/FCF	4.64	EPS past 5Y	1.91%	ROI	-39.75%	52W High	-61.18%	Beta	0.89
Dividend TTM	-	Quick Ratio	1.59	Sales past 5Y	48.49%	Gross Margin	55.99%	52W Low	29.44%	ATR (14)	0.47
Dividend Ex-Date	-	Current Ratio	1.62	EPS Y/Y TTM	76.07%	Oper. Margin	-8.23%	RSI (14)	62.06	Volatility	5.00% 5.23%
Employees	5600	Debt/Eq	1.06	Sales Y/Y TTM	3.10%	Profit Margin	-38.54%	Recom	2.61	Target Price	9.90
Option/Short	Yes / Yes	LT Debt/Eq	0.68	EPS Q/Q	-1139.50%	Payout	-	Rel Volume	1.24	Prev Close	9.18
Sales Surprise	-1.03%	EPS Surprise	-1327.74%	Sales Q/Q	-1.53%	Earnings	Jul 31 AMC	Avg Volume	6.96M	Price	8.75
SMA20	14.33%	SMA50	8.19%	SMA200	-35.95%	Trades		Volume	8,621,762	Change	-4.68%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-17-24	Reiterated	Jefferies	Hold	$8 → $10
Feb-29-24	Initiated	Cantor Fitzgerald	Overweight	$22
Feb-26-24	Initiated	Leerink Partners	Market Perform	$17
Jan-17-24	Downgrade	DA Davidson	Buy → Neutral	$33 → $22
Jan-03-24	Initiated	Barclays	Overweight	$26
Apr-12-23	Initiated	Stephens	Equal-Weight	$25
Feb-23-23	Upgrade	SVB Securities	Market Perform → Outperform	$34
Oct-24-22	Upgrade	Guggenheim	Sell → Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold	$35
Aug-17-22	Downgrade	Guggenheim	Neutral → Sell	$25
Aug-12-22	Initiated	DA Davidson	Buy	$45
Aug-02-22	Downgrade	Cowen	Outperform → Market Perform	$58 → $34
Aug-02-22	Downgrade	Berenberg	Buy → Hold	$35
Jul-28-22	Downgrade	Needham	Buy → Hold
Jul-28-22	Downgrade	Goldman	Buy → Neutral	$55 → $36
Jul-06-22	Reiterated	BofA Securities	Neutral	$36 → $42
May-05-22	Downgrade	Argus	Buy → Hold
Apr-28-22	Downgrade	William Blair	Outperform → Mkt Perform
Apr-28-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$104 → $40

Show Previous Ratings

Today 04:47AM	Q2 Earnings Highs And Lows: Teladoc (NYSE:TDOC) Vs The Rest Of The Online Marketplace Stocks (StockStory)
Sep-17-24 05:52PM	Why Teladoc Stock Popped by Nearly 12% on Tuesday (Motley Fool) +11.64%
04:19PM	Teladoc stock surges after Jefferies raises price target (Yahoo Finance Video)
01:57PM	Why Are Teladoc (TDOC) Shares Soaring Today (StockStory)
07:00AM	1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc) (Motley Fool)
06:15PM	Loading…
Sep-16-24 06:15PM	Why Teladoc (TDOC) Outpaced the Stock Market Today (Zacks)
05:01AM	Q2 Earnings Review: Online Marketplace Stocks Led by EverQuote (NASDAQ:EVER) (StockStory)
Sep-13-24 03:18AM	Reflecting On Online Marketplace Stocks Q2 Earnings: Shutterstock (NYSE:SSTK) (StockStory) +6.17%
Sep-11-24 07:50AM	Is Hims & Hers Health the Next Teladoc? (Motley Fool)
Sep-10-24 06:15PM	Why Teladoc (TDOC) Outpaced the Stock Market Today (Zacks)
03:46AM	Q2 Rundown: The RealReal (NASDAQ:REAL) Vs Other Online Marketplace Stocks (StockStory)
Sep-09-24 03:51AM	Online Marketplace Stocks Q2 Teardown: Sea (NYSE:SE) Vs The Rest (StockStory)
Sep-08-24 03:58PM	Teladoc Health, Inc. (TDOC): Among the Worst ARK Stocks According to Short Sellers (Insider Monkey)
11:49AM	10 Worst ARK Stocks To Buy According To Short Sellers (Insider Monkey)
Sep-06-24 04:30PM	Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 (GlobeNewswire)
10:36AM	Loading…
10:36AM	Heres Why Brown Capital Management Mid Company Fund Exited Teladoc Health (TDOC) (Insider Monkey)
Sep-05-24 07:18PM	Insider Sale at Teladoc Health Inc (TDOC): EVP Andrew Turitz Sells 20,773 Shares (GuruFocus.com)
08:32AM	15 Healthiest Countries in Europe (Insider Monkey)
Aug-30-24 06:15PM	Here's Why Teladoc (TDOC) Gained But Lagged the Market Today (Zacks)
03:13AM	Unpacking Q2 Earnings: CarGurus (NASDAQ:CARG) In The Context Of Other Online Marketplace Stocks (StockStory)
Aug-28-24 07:00PM	Teladoc Health, Inc. (TDOC): Among The Best Medical AI Companies (Insider Monkey)
Aug-18-24 07:03AM	Is There Any Hope for Teladoc Stock? (Motley Fool)
Aug-08-24 11:31PM	Insider Sale: Chief Marketing Officer of Teladoc Health Inc (TDOC) Sells Shares (GuruFocus.com)
Aug-02-24 01:11PM	Teladoc Health (TDOC) Shares Down 8.9% Despite Q2 Earnings Beat (Zacks) -7.45%
06:55AM	Get Your Money Out of These 3 Healthcare Stocks ASAP (InvestorPlace)
Aug-01-24 04:21PM	These Stocks Moved the Most Today: Meta, Moderna, Qualcomm, Arm, Western Digital, Apple, Amazon, Intel, and More (Barrons.com) -8.91%
01:28PM	Teladoc (TDOC) Stock Trades Down, Here Is Why (StockStory)
12:53PM	These Stocks Are Moving the Most Today: Meta, Moderna, Qualcomm, Arm, Western Digital, Apple, Amazon, Intel, and More (Barrons.com)
10:36AM	Why Teladoc Stock Got Socked for a Loss Thursday (Motley Fool)
05:37AM	Teladoc withdraws 2024 outlook, logs impairment charge amid downturn at BetterHelp (Healthcare Dive)
11:15PM	Loading…
Jul-31-24 11:15PM	Teladoc Health (TDOC) Q2 2024 Earnings Call Transcript (Motley Fool)
09:56PM	TDOC Stock Earnings: Teladoc Health Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
06:00PM	Teladoc (TDOC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:40PM	Carvana, Etsy, Teladoc: After-hours movers (Yahoo Finance Video)
05:30PM	Teladoc (TDOC) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:27PM	Teladoc (NYSE:TDOC) Misses Q2 Revenue Estimates, Stock Drops 15.6% (StockStory)
04:33PM	Teladoc: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Teladoc Health Reports Second Quarter 2024 Results (GlobeNewswire)
Jul-30-24 03:05AM	Teladoc (TDOC) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-29-24 12:05PM	Can Teladoc (TDOC) Q2 Earnings Navigate BetterHelp Profit Woes? (Zacks)
09:16AM	Countdown to Teladoc (TDOC) Q2 Earnings: Wall Street Forecasts for Key Metrics (Zacks)
07:10AM	Q1 Earnings Roundup: Teladoc (NYSE:TDOC) And The Rest Of The Online Marketplace Segment (StockStory)
Jul-25-24 06:00AM	Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future (News Direct)
Jul-23-24 06:15PM	Teladoc (TDOC) Ascends While Market Falls: Some Facts to Note (Zacks)
Jul-19-24 10:30AM	3 Tech Stocks That Could Grow Your Wealth (InvestorPlace)
Jul-17-24 04:30PM	Teladoc Health to Announce Second Quarter 2024 Financial Results (GlobeNewswire) -7.18%
06:15AM	Teladoc Health and Brightline launch comprehensive mental health services (Hospital Management)
Jul-16-24 08:00AM	Teladoc Health Introduces Pediatric, Adolescent and Family Mental Healthcare Through Partnership with Brightline (GlobeNewswire) +8.96%
07:05AM	3 Overlooked Telehealth Stocks Poised for a Comeback (InvestorPlace)
Jul-14-24 10:00AM	2 Healthcare Stocks to Buy at a Discount (Motley Fool)
Jul-12-24 06:15PM	Teladoc (TDOC) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
Jul-11-24 05:00PM	Teladoc Health Is Providing Free Virtual Health Care Services to Texas Residents Impacted by Hurricane Beryl (GlobeNewswire)
Jul-09-24 09:29AM	3 Growth Stocks Even Permabull' Cathie Wood Is Selling (InvestorPlace)
Jul-08-24 04:05PM	Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 (GlobeNewswire)
10:20AM	Teladocs enterprise growth exec to depart (Healthcare Dive)
Jul-01-24 08:28PM	Teladoc Health, Inc. (TDOC): Best Stock to Buy and Hold For 5 Years According to Cathie Wood? (Insider Monkey)
02:31PM	10 Best Stocks to Buy and Hold For 5 Years According to Cathie Wood (Insider Monkey)
06:40AM	7 F-Rated Blue-Chip Stocks That'll Have You Seeing Red (InvestorPlace)
Jun-28-24 04:43AM	Q1 Earnings Outperformers: Cars.com (NYSE:CARS) And The Rest Of The Online Marketplace Stocks (StockStory)
Jun-27-24 06:15PM	Teladoc (TDOC) Stock Declines While Market Improves: Some Information for Investors (Zacks)
08:00AM	7 Must-Have Growth Stocks to Hold Until 2031 (InvestorPlace)
Jun-25-24 12:00PM	Teladoc (TDOC) Harnesses AI for Diabetes Care, Stock Rises 6.7% (Zacks) -5.89%
08:00AM	Teladoc (TDOC) Soars 6.7%: Is Further Upside Left in the Stock? (Zacks)
Jun-24-24 06:02PM	Crypto under pressure, Good Buy or Goodbye: Market Domination (Yahoo Finance Video) +6.69%
04:02PM	Teladoc study shows AI model improving diabetes management (Yahoo Finance Video)
12:33PM	The 7 Smartest Cathie Wood Stocks to Buy With $10K Right Now (InvestorPlace)
10:45AM	2 Disruptor Stocks to Buy and Hold for Great Long-Term Potential (Motley Fool)
08:00AM	Teladoc Health's predictive AI-modeling leads to increased engagement among diabetes members, driving additional A1c reduction, new research shows (GlobeNewswire)
Jun-21-24 06:45PM	Teladoc Health is Providing Free Virtual Health Care Services to New Mexico Residents Impacted by Wildfires (GlobeNewswire)
Jun-17-24 06:15PM	Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know (Zacks)
07:46AM	TDOC INVESTOR NOTICE: Teladoc Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Case (Newsfile)
Jun-16-24 07:02AM	3 Tech Stock Leaders Set to Profit After the Pullback (InvestorPlace)
Jun-14-24 05:45AM	Investors in Teladoc Health, Inc. Should Contact Levi & Korsinsky Before July 16, 2024 to Discuss Your Rights - TDOC (PR Newswire)
Jun-10-24 06:15PM	Teladoc (TDOC) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
03:13PM	Small-Cap Champions: 7 David-Like Stocks Ready to Take Down the Goliaths (InvestorPlace)
03:03PM	Celebrating Shakespeare; Talking About Investing (Motley Fool)
06:45AM	Teladoc Health Names Chuck Divita as CEO (GlobeNewswire)
06:23AM	Teladoc Health names former insurance exec as new CEO (Healthcare Dive)
Jun-08-24 02:00PM	3 Cathie Wood Stocks That Could Be Coiled Springs (InvestorPlace)
Jun-05-24 07:09AM	Online Marketplace Stocks Q1 Highlights: Teladoc (NYSE:TDOC) (StockStory)
Jun-04-24 06:15PM	Teladoc (TDOC) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Jun-03-24 02:05PM	The 3 Most Undervalued Cathie Wood Stocks to Buy in June 2024 (InvestorPlace)
May-31-24 05:45AM	Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You? (Motley Fool)
May-30-24 12:39PM	Shareholders of Teladoc Health, Inc. Should Contact Levi & Korsinsky Before July 16, 2024 to Discuss Your Rights TDOC (GlobeNewswire)
May-29-24 06:15PM	Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
12:26PM	Shareholders of Teladoc Health, Inc. Should Contact Levi & Korsinsky Before July 16, 2024 to Discuss Your Rights TDOC (GlobeNewswire)
May-28-24 02:01PM	3 Sorry Healthcare Stocks to Sell in May While You Still Can (InvestorPlace)
May-24-24 07:00PM	Insider Selling: Karen Daniel Sells Shares of Teladoc Health Inc (TDOC) (GuruFocus.com)
May-21-24 04:30PM	Buy the Dip: 3 Stocks Ready to Rebound for Big Returns (InvestorPlace)
12:50PM	JPMorgan Adjusts Teladoc Price Target to $16 From $19, Maintains Neutral Rating (MT Newswires)
May-16-24 08:13PM	From Hype to Bust: The Downfall of Teladoc, Bark and Nike Stocks (InvestorPlace)
09:45AM	2 Top Growth Stocks Down 24% and 50% to Buy With $100 (Motley Fool)
May-14-24 04:45PM	3 High-Potential Stocks to Buy at Rock-Bottom Prices (InvestorPlace)
07:16AM	13 Best Affordable Stocks Under $40 (Insider Monkey)
May-10-24 06:01AM	The 3 Most Undervalued Healthcare Stocks to Buy in May 2024 (InvestorPlace)
May-08-24 09:00AM	Here is What to Know Beyond Why Teladoc Health, Inc. (TDOC) is a Trending Stock (Zacks) -5.28%
May-07-24 01:53PM	'Telehealth 1.0 is dead,' but don't count out digital health just yet (Yahoo Finance)
May-03-24 03:44PM	Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Q1 2024 Earnings Call Transcript (Insider Monkey)
01:11PM	WW International, Inc. (NASDAQ:WW) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:30AM	Insider Sale at Teladoc Health Inc (TDOC): President of Enterprise Growth Sells Shares (GuruFocus.com)

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Trencher Daniel	Former Officer	Sep 16 '24	Proposed Sale	8.21	9,960	81,773		Sep 16 03:35 PM
MCKINLEY THOMAS	Director	Sep 12 '24	Buy	7.69	4,000	30,756	39,077	Sep 13 05:14 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Sep 04 '24	Sale	7.26	20,773	150,812	20,773	Sep 05 04:05 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Sep 04 '24	Sale	7.26	468	3,398	33,665	Sep 05 04:05 PM
Geshuri Arnnon	CHIEF PEOPLE OFFICER	Sep 03 '24	Sale	7.16	1,795	12,859	44,914	Sep 04 04:13 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Sep 03 '24	Sale	7.16	8,750	62,685	85,767	Sep 04 04:13 PM
Nanis Nikolaos P.	Chief Technology Officer	Sep 03 '24	Sale	7.16	1,033	7,400	75,410	Sep 04 04:12 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Sep 03 '24	Sale	7.16	2,817	20,181	46,250	Sep 04 04:12 PM
Verstraete Stephany	CHIEF MARKETING OFFICER	Sep 03 '24	Sale	7.16	2,083	14,923	48,843	Sep 04 04:12 PM
Cave James L.	INTERIM CAO	Sep 03 '24	Sale	7.16	555	3,976	13,808	Sep 04 04:12 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Sep 03 '24	Sale	7.16	1,777	12,730	31,465	Sep 04 04:12 PM
Waters Michael Willem	CHIEF OPERATING OFFICER	Sep 03 '24	Sale	7.16	4,218	30,218	78,309	Sep 04 04:11 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Sep 03 '24	Sale	7.16	1,617	11,584	41,546	Sep 04 04:11 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Sep 03 '24	Sale	7.16	1,114	7,981	34,133	Sep 04 04:11 PM
Raman-Tangella Vidya	Officer	Sep 04 '24	Proposed Sale	7.26	468	3,398		Sep 04 10:25 AM
Turitz Andrew	Officer	Sep 04 '24	Proposed Sale	7.26	20,773	150,812		Sep 04 10:18 AM
Geshuri Arnnon	Officer	Sep 03 '24	Proposed Sale	7.16	1,795	12,859		Sep 03 04:06 PM
Nanis Nikolaos P.	Officer	Sep 03 '24	Proposed Sale	7.16	1,033	7,400		Sep 03 03:54 PM
Murthy Mala	Officer	Sep 03 '24	Proposed Sale	7.16	8,750	62,681		Sep 03 03:49 PM
Verstraete Stephany	Officer	Sep 03 '24	Proposed Sale	7.16	2,083	14,922		Sep 03 03:41 PM
Waters Michael Willem	Officer	Sep 03 '24	Proposed Sale	7.16	4,218	30,216		Sep 03 03:35 PM
Vandervoort Adam C	Officer	Sep 03 '24	Proposed Sale	7.16	2,817	20,180		Sep 03 03:32 PM
Raman-Tangella Vidya	Officer	Sep 03 '24	Proposed Sale	7.16	1,114	7,980		Sep 03 03:27 PM
Trencher Daniel	Officer	Sep 03 '24	Proposed Sale	7.16	1,777	12,730		Sep 03 03:13 PM
Turitz Andrew	Officer	Sep 03 '24	Proposed Sale	7.17	1,617	11,587		Sep 03 03:09 PM
Smith Mark Douglas	Director	Aug 15 '24	Buy	7.08	4,000	28,312	8,355	Aug 19 04:10 PM
Nanis Nikolaos P.	Chief Technology Officer	Aug 12 '24	Sale	7.13	206	1,470	73,588	Aug 13 04:16 PM
Nanis Nikolaos P.	Officer	Aug 12 '24	Proposed Sale	7.14	206	1,470		Aug 12 03:28 PM
Verstraete Stephany	CHIEF MARKETING OFFICER	Aug 07 '24	Sale	7.60	15,000	114,000	45,158	Aug 08 05:51 PM
MCKINLEY THOMAS	Director	Aug 06 '24	Buy	7.57	7,000	52,990	31,077	Aug 08 05:49 PM
MCKINLEY THOMAS	Director	Aug 07 '24	Buy	7.19	4,000	28,756	35,077	Aug 08 05:49 PM
Verstraete Stephany	Officer	Aug 07 '24	Proposed Sale	7.60	15,000	114,000		Aug 07 12:14 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Aug 05 '24	Sale	7.33	1,537	11,266	32,130	Aug 06 06:10 PM
Waters Michael Willem	CHIEF OPERATING OFFICER	Aug 02 '24	Sale	8.14	6,053	49,284	74,214	Aug 05 05:01 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Aug 02 '24	Sale	8.14	3,857	31,404	33,667	Aug 05 04:59 PM
Kornwasser Laizer	Advisor to the CEO	Aug 02 '24	Sale	8.14	10,879	88,577	99,929	Aug 05 04:56 PM
Raman-Tangella Vidya	Officer	Aug 05 '24	Proposed Sale	7.33	1,537	11,266		Aug 05 11:11 AM
Waters Michael Willem	Officer	Aug 02 '24	Proposed Sale	8.14	6,053	49,285		Aug 02 03:27 PM
Raman-Tangella Vidya	Officer	Aug 02 '24	Proposed Sale	8.14	3,857	31,404		Aug 02 03:22 PM
Kornwasser Laizer	Officer	Aug 02 '24	Proposed Sale	8.14	10,879	88,579		Aug 02 03:18 PM
Nanis Nikolaos P.	Chief Technology Officer	Jul 02 '24	Sale	9.39	442	4,150	73,226	Jul 02 05:00 PM
Murthy Mala	ACTING CEO, CFO	Jun 03 '24	Sale	11.16	8,807	98,260	78,713	Jun 04 04:07 PM
Geshuri Arnnon	CHIEF PEOPLE OFFICER	Jun 03 '24	Sale	11.16	1,807	20,161	41,686	Jun 04 04:07 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Jun 03 '24	Sale	11.16	1,627	18,152	37,659	Jun 04 04:06 PM
Waters Michael Willem	CHIEF OPERATING OFFICER	Jun 03 '24	Sale	11.16	4,246	47,373	68,948	Jun 04 04:06 PM
Kornwasser Laizer	PRESIDENT, ENTERPRISE GROWTH	Jun 03 '24	Sale	11.16	4,812	53,687	90,610	Jun 04 04:06 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	May 31 '24	Sale	11.21	3,407	38,192	28,870	Jun 04 04:06 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Jun 03 '24	Sale	11.16	1,122	12,518	27,748	Jun 04 04:06 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Jun 04 '24	Sale	11.04	468	5,167	27,280	Jun 04 04:06 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Jun 03 '24	Sale	11.16	1,790	19,971	28,322	Jun 04 04:06 PM
Verstraete Stephany	CHIEF MARKETING OFFICER	Jun 03 '24	Sale	11.16	2,096	23,385	60,158	Jun 04 04:05 PM
Cave James L.	INTERIM CAO	Jun 03 '24	Sale	11.16	854	9,528	12,479	Jun 04 04:05 PM
Nanis Nikolaos P.	Chief Technology Officer	Jun 03 '24	Sale	11.16	1,040	11,603	72,435	Jun 04 04:05 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Jun 03 '24	Sale	11.16	4,015	44,795	41,264	Jun 04 04:05 PM
Daniel Karen L	Director	May 23 '24	Sale	11.90	9,834	117,025	36,995	May 24 04:26 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	May 17 '24	Sale	12.83	1,000	12,830	25,192	May 17 04:05 PM
Kornwasser Laizer	PRESIDENT, ENTERPRISE GROWTH	May 02 '24	Sale	12.69	10,411	132,095	86,070	May 02 04:06 PM
Waters Michael Willem	CHIEF OPERATING OFFICER	May 02 '24	Sale	12.69	5,793	73,502	64,881	May 02 04:05 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	May 02 '24	Sale	12.69	3,691	46,831	29,160	May 02 04:05 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Apr 17 '24	Sale	13.21	1,000	13,210	26,192	Apr 17 04:54 PM
Nanis Nikolaos P.	Chief Technology Officer	Apr 02 '24	Sale	14.31	461	6,599	70,621	Apr 03 04:05 PM
Geshuri Arnnon	CHIEF PEOPLE OFFICER	Mar 25 '24	Option Exercise	2.73	7,500	20,475	45,970	Mar 26 04:05 PM
Geshuri Arnnon	CHIEF PEOPLE OFFICER	Mar 25 '24	Sale	15.06	7,500	112,950	38,470	Mar 26 04:05 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Mar 18 '24	Sale	15.18	1,000	15,180	27,192	Mar 18 04:56 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Mar 05 '24	Sale	14.53	5,647	82,051	33,782	Mar 06 04:05 PM
Kornwasser Laizer	PRESIDENT, ENTERPRISE GROWTH	Mar 04 '24	Sale	14.52	18,349	266,354	76,283	Mar 05 04:11 PM
Napolitano Richard J	CHIEF ACCOUNTING OFFICER	Mar 04 '24	Sale	14.52	3,765	54,653	18,077	Mar 05 04:11 PM
Waters Michael Willem	CHIEF OPERATING OFFICER	Mar 04 '24	Sale	14.52	12,468	180,985	59,355	Mar 05 04:10 PM
Verstraete Stephany	CHIEF MARKETING OFFICER	Mar 04 '24	Sale	14.52	7,945	115,330	56,486	Mar 05 04:10 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Mar 04 '24	Sale	14.52	15,653	227,219	37,476	Mar 05 04:09 PM
GOREVIC JASON N	CHIEF EXECUTIVE OFFICER	Mar 04 '24	Sale	14.52	53,755	780,308	653,073	Mar 05 04:09 PM
Nanis Nikolaos P.	Chief Technology Officer	Mar 04 '24	Sale	14.52	2,866	41,603	69,850	Mar 05 04:09 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Mar 04 '24	Sale	14.52	4,599	66,759	22,607	Mar 05 04:08 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Mar 04 '24	Sale	14.52	6,190	89,854	39,429	Mar 05 04:08 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Mar 01 '24	Sale	15.06	475	7,154	25,193	Mar 05 04:08 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Mar 04 '24	Sale	14.52	6,780	98,418	28,192	Mar 05 04:08 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Mar 04 '24	Sale	14.52	29,888	433,854	71,716	Mar 05 04:07 PM
Geshuri Arnnon	CHIEF PEOPLE OFFICER	Mar 04 '24	Sale	14.52	6,108	88,664	38,470	Mar 05 04:07 PM
Geshuri Arnnon	CHIEF PEOPLE OFFICER	Feb 26 '24	Sale	14.50	404	5,859	28,020	Feb 27 04:06 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Feb 20 '24	Sale	20.64	1,000	20,640	16,788	Feb 20 05:02 PM
Waters Michael Willem	CHIEF OPERATING OFFICER	Feb 02 '24	Sale	19.18	4,523	86,742	38,570	Feb 02 05:04 PM
Kornwasser Laizer	PRESIDENT, ENTERPRISE GROWTH	Feb 02 '24	Sale	19.18	7,882	151,161	57,223	Feb 02 05:04 PM
Napolitano Richard J	CHIEF ACCOUNTING OFFICER	Feb 02 '24	Sale	19.18	872	16,723	11,749	Feb 02 05:04 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Feb 02 '24	Sale	19.18	4,128	79,167	14,737	Feb 02 05:03 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Jan 17 '24	Sale	19.46	1,000	19,460	17,788	Jan 18 04:06 PM
Nanis Nikolaos P.	Chief Technology Officer	Jan 03 '24	Sale	21.36	520	11,107	65,031	Jan 04 04:05 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Dec 26 '23	Sale	22.00	27,310	600,820	8,621	Dec 27 04:05 PM
Daniel Karen L	Director	Dec 20 '23	Sale	21.41	14,073	301,303	36,995	Dec 21 04:05 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Dec 18 '23	Sale	20.36	1,000	20,360	18,788	Dec 19 04:05 PM
Napolitano Richard J	CHIEF ACCOUNTING OFFICER	Dec 04 '23	Sale	18.90	652	12,324	10,601	Dec 05 04:08 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Dec 04 '23	Sale	18.90	3,004	56,782	49,315	Dec 05 04:07 PM
Verstraete Stephany	CHIEF MARKETING OFFICER	Dec 04 '23	Sale	18.90	509	9,621	43,117	Dec 05 04:07 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Dec 04 '23	Sale	18.90	965	18,240	23,467	Dec 05 04:07 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Dec 04 '23	Sale	18.90	427	8,071	19,788	Dec 05 04:06 PM
Nanis Nikolaos P.	Chief Technology Officer	Dec 04 '23	Sale	18.90	508	9,602	64,319	Dec 05 04:06 PM
GOREVIC JASON N	CHIEF EXECUTIVE OFFICER	Dec 04 '23	Sale	18.90	2,877	54,381	601,734	Dec 05 04:06 PM
Geshuri Arnnon	CHIEF PEOPLE OFFICER	Dec 04 '23	Sale	18.90	410	7,750	28,424	Dec 05 04:06 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Dec 04 '23	Sale	18.90	397	7,504	25,668	Dec 05 04:05 PM
Geshuri Arnnon	CHIEF PEOPLE OFFICER	Nov 27 '23	Sale	17.04	346	5,896	27,655	Nov 28 09:36 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Nov 17 '23	Sale	17.07	1,000	17,070	19,036	Nov 20 04:05 PM

Open in Screener

PHR

Phreesia Inc

Sep 20 • 04:00PM ET

23.59

Dollar change -0.17
Percentage change -0.72	%

Healthcare • Health Information Services • USA • NYSE

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI IWM VXF VB IWO VBK SCHA VTWO VHT FESM

Index	RUT	P/E	-	EPS (ttm)	-1.80	Insider Own	6.62%	Shs Outstand	56.35M	Perf Week	-4.46%
Market Cap	1.36B	Forward P/E	-	EPS next Y	-0.62	Insider Trans	-3.75%	Shs Float	53.95M	Perf Month	-5.07%
Income	-100.32M	PEG	-	EPS next Q	-0.27	Inst Own	94.64%	Short Float	4.93%	Perf Quarter	16.49%
Sales	389.96M	P/S	3.49	EPS this Y	52.76%	Inst Trans	-5.29%	Short Ratio	6.54	Perf Half Y	0.04%
Book/sh	4.36	P/B	5.42	EPS next Y	48.06%	ROA	-28.55%	Short Interest	2.66M	Perf Year	25.15%
Cash/sh	1.42	P/C	16.66	EPS next 5Y	-	ROE	-40.26%	52W Range	12.05 - 29.16	Perf YTD	1.90%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-15.39%	ROI	-38.63%	52W High	-19.09%	Beta	0.94
Dividend TTM	-	Quick Ratio	1.77	Sales past 5Y	29.21%	Gross Margin	58.96%	52W Low	95.77%	ATR (14)	1.29
Dividend Ex-Date	-	Current Ratio	1.77	EPS Y/Y TTM	37.24%	Oper. Margin	-24.58%	RSI (14)	46.71	Volatility	4.84% 5.36%
Employees	1438	Debt/Eq	0.07	Sales Y/Y TTM	22.10%	Profit Margin	-25.73%	Recom	1.29	Target Price	29.31
Option/Short	Yes / Yes	LT Debt/Eq	0.03	EPS Q/Q	54.18%	Payout	-	Rel Volume	2.66	Prev Close	23.76
Sales Surprise	0.51%	EPS Surprise	12.45%	Sales Q/Q	18.97%	Earnings	Sep 04 AMC	Avg Volume	406.79K	Price	23.59
SMA20	-3.80%	SMA50	-1.50%	SMA200	2.21%	Trades		Volume	1,082,457	Change	-0.72%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-26-24	Initiated	Truist	Buy	$35
Jan-17-24	Upgrade	DA Davidson	Neutral → Buy	$30 → $32
Jan-03-24	Initiated	Barclays	Overweight	$29
Apr-12-23	Initiated	Stephens	Overweight	$37
Jan-04-23	Reiterated	Needham	Buy	$35 → $40
Dec-13-22	Upgrade	Citigroup	Neutral → Buy	$40
Dec-09-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$31 → $34
Oct-13-22	Initiated	DA Davidson	Neutral	$25
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight	$40
Apr-14-22	Initiated	Guggenheim	Buy	$45
Jan-06-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$57 → $41
Dec-02-21	Initiated	Jefferies	Buy	$70
Sep-02-21	Reiterated	Needham	Buy	$70 → $81
Aug-27-21	Initiated	Canaccord Genuity	Buy	$81
Jul-13-21	Initiated	JMP Securities	Mkt Outperform	$80
Jun-08-21	Initiated	Berenberg	Buy	$70
Apr-29-21	Resumed	JP Morgan	Overweight	$64
Apr-01-21	Initiated	Robert W. Baird	Outperform	$60
Nov-11-20	Initiated	Stephens	Overweight	$50
Oct-27-20	Initiated	Needham	Buy	$44

Show Previous Ratings

Sep-19-24 06:48AM	New Research Shows Point-of-Care Patient Outreach Supports Vaccine Confidence and Adoption (Business Wire)
Sep-17-24 04:28PM	CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence (Business Wire)
Sep-05-24 12:39PM	Q2 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) +6.29%
Sep-04-24 06:00PM	Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:15PM	Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:15PM	Loading…
04:15PM	Phreesia: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Second Quarter Fiscal 2025 Results (Business Wire)
Sep-03-24 09:03AM	Earnings To Watch: Phreesia Inc (PHR) Reports Q2 2025 Result (GuruFocus.com) -7.43%
Aug-29-24 09:15AM	Phreesia (PHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
06:48AM	Phreesia and American Academy of Pediatrics Join in Campaign to Increase Childhood MMR Vaccination (Business Wire)
Aug-08-24 06:48AM	Bob Glazer Joins Phreesia as Strategic Advisor (Business Wire)
Aug-05-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Salesforce, and Phreesia and Encourages Investors to Contact the Firm (GlobeNewswire)
Aug-01-24 06:48AM	Phreesia Sets Release Date for Fiscal Second Quarter 2025 Results (Business Wire)
Jul-30-24 06:48AM	Phreesia Now Available on Oracle Healthcare Marketplace (Business Wire)
Jul-19-24 09:55AM	Wall Street Analysts Think Phreesia (PHR) Could Surge 27.77%: Read This Before Placing a Bet (Zacks)
12:00PM	Loading…
Jul-12-24 12:00PM	Phreesia (PHR) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jun-10-24 10:26AM	New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease (Business Wire)
Jun-04-24 09:35AM	Here's Why Phreesia (PHR) is Poised for a Turnaround After Losing -18.25% in 4 Weeks (Zacks)
May-31-24 11:59AM	Q1 2025 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) -11.22%
May-30-24 08:54PM	PHR Stock Earnings: Phreesia Beats EPS, Beats Revenue for Q1 2025 (InvestorPlace)
05:30PM	Compared to Estimates, Phreesia (PHR) Q1 Earnings: A Look at Key Metrics (Zacks)
05:15PM	Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:08PM	Phreesia: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces First Quarter Fiscal 2025 Results (Business Wire)
May-28-24 06:48AM	Phreesia Joins the MEDITECH Alliance Program as an Innovator Partner (Business Wire)
May-24-24 09:15AM	Unlocking Q1 Potential of Phreesia (PHR): Exploring Wall Street Estimates for Key Metrics (Zacks)
May-23-24 04:30PM	Phreesias Amy Patel Named One of PM360s 2024 ELITE 100 (Business Wire)
May-21-24 04:30PM	Phreesia Named as One of Modern Healthcares Best Places to Work in Healthcare for the Eighth Time (Business Wire)
May-01-24 06:46AM	Phreesias Alicia Cowley and Natasha Vega Named to MM+Ms Women to Watch for 2024 (Business Wire)
Apr-29-24 06:48AM	Phreesia Sets Release Date for Fiscal First Quarter 2025 Results (Business Wire)
07:01PM	Loading…
Mar-25-24 07:01PM	Insider Sell: COO Evan Roberts Sells 25,962 Shares of Phreesia Inc (PHR) (GuruFocus.com)
Mar-19-24 06:48AM	Phreesia Announces Jack Callahan as New Chief Technology Officer (Business Wire)
Mar-17-24 10:22AM	Phreesia, Inc. (NYSE:PHR) Q4 2024 Earnings Call Transcript (Insider Monkey)
Mar-15-24 06:56AM	Q4 2024 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-24 08:55PM	PHR Stock Earnings: Phreesia Misses EPS, Beats Revenue for Q4 2024 (InvestorPlace)
06:00PM	Phreesia (PHR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:22PM	Phreesia: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Fourth Quarter Fiscal 2024 Results (Business Wire)
Mar-07-24 10:00AM	Will Phreesia (PHR) Report Negative Earnings Next Week? What You Should Know (Zacks)
Feb-27-24 04:05PM	Phreesias Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium (Business Wire)
Feb-20-24 06:48AM	New Data Shows That Engaging Patients with Relevant Cancer-Prevention Information During Check-In Increases Screening Rates (Business Wire) -6.32%
Feb-19-24 11:53AM	Phreesia (PHR) Rose on 2024 Guidance (Insider Monkey)
Feb-05-24 04:05PM	Phreesia Sets Release Date for Fiscal Fourth Quarter 2024 Results (Business Wire)
06:54AM	Bull Of The Day: Phreesia (PHR) (Zacks)
Jan-23-24 06:40AM	Phreesia Joins Call to Action to Improve Adult Vaccination Rates (Business Wire)
Jan-18-24 07:59PM	Phreesia Inc CFO Balaji Gandhi Sells 10,124 Shares (GuruFocus.com)
Jan-16-24 04:05PM	Phreesias Audrey Gato Named as a Top Woman Leader in SaaS (Business Wire)
Jan-11-24 06:44AM	Phreesias Post-Script Engagement named one of PM360s 2023 Most Innovative Technologies (Business Wire)
Dec-27-23 09:55AM	Does Phreesia (PHR) Have the Potential to Rally 30.09% as Wall Street Analysts Expect? (Zacks)
08:06AM	What Caused a -40% Drop in Phreesia (PHR) Shares? (Insider Monkey)
Dec-11-23 09:55AM	Wall Street Analysts Predict a 77.77% Upside in Phreesia (PHR): Here's What You Should Know (Zacks)
Dec-08-23 08:21AM	Phreesia, Inc. (NYSE:PHR) Q3 2024 Earnings Call Transcript (Insider Monkey)
Dec-06-23 10:37AM	Q3 2024 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents) +21.22%
Dec-05-23 06:00PM	Here's What Key Metrics Tell Us About Phreesia (PHR) Q3 Earnings (Zacks)
05:40PM	Phreesia Inc (PHR) Reports Revenue Growth and Narrowed Net Loss in Q3 Fiscal 2024 (GuruFocus.com)
05:15PM	Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:17PM	Phreesia: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:03PM	Phreesia Announces Third Quarter Fiscal 2024 Results (Business Wire)
Dec-01-23 06:00AM	CMS Includes the Patient Activation Measure in its Merit-Based Incentive Payment System Starting in 2024 (Business Wire)
Nov-16-23 03:12AM	Here's Why Phreesia (PHR) Declined in Q3 (Insider Monkey)
Nov-08-23 06:00AM	Phreesia Achieves HITRUST Risk-Based, 2-Year Certification Demonstrating the Highest Level of Information Protection Assurance (Business Wire)
Nov-01-23 09:12AM	Phreesia (PHR) Surges 10.3%: Is This an Indication of Further Gains? (Zacks)
06:03AM	Phreesia Sets Release Date for Fiscal Third Quarter 2024 Results (Business Wire)
Sep-15-23 10:01PM	Insider Sell: Evan Roberts Sells 3,907 Shares of Phreesia Inc (PHR) (GuruFocus.com)
Sep-14-23 09:39PM	Principal Accounting Officer Janet Gunzburg Sells 934 Shares of Phreesia Inc (GuruFocus.com)
Sep-11-23 12:11PM	Phreesia Inc (PHR): A Deep Dive into Its Performance Potential (GuruFocus.com)
Sep-07-23 12:08PM	Phreesia Inc (PHR): A Deep Dive into Its Performance Potential (GuruFocus.com) -22.11%
11:45AM	Is Phreesia (PHR) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
09:30AM	Compared to Estimates, Phreesia (PHR) Q2 Earnings: A Look at Key Metrics (Zacks)
09:00AM	Phreesia, Inc. (NYSE:PHR) Q2 2024 Earnings Call Transcript (Insider Monkey)
07:37AM	Q2 2024 Phreesia Inc Earnings Call (Thomson Reuters StreetEvents)
Sep-06-23 05:15PM	Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:07PM	Phreesia: Fiscal Q2 Earnings Snapshot (AP Finance)
04:03PM	Phreesia Announces Second Quarter Fiscal 2024 Results (Business Wire)
Sep-04-23 12:00PM	All You Need to Know About Phreesia (PHR) Rating Upgrade to Buy (Zacks)
09:55AM	How Much Upside is Left in Phreesia (PHR)? Wall Street Analysts Think 27.26% (Zacks)
08:39AM	Nextgen Healthcare (NXGN) Surges 6.2%: Is This an Indication of Further Gains? (Zacks)
Aug-31-23 08:40AM	Should You Buy and Phreesia (PHR) Ahead of Earnings? (Zacks)
Aug-16-23 12:58PM	Phreesia Named to The Software Reports "Top 100 Software Companies" for the Second Consecutive Year (Business Wire)
Aug-15-23 05:11PM	Phreesia Awards Inducement Grants as Part of its Acquisition of Access eForms (Business Wire)
Aug-14-23 04:03PM	Phreesia Acquires Access, Expanding its Offerings for Acute-Care Hospitals and Continuing to Drive Efficiency and a Better Patient Experience (Business Wire)
Aug-07-23 06:50PM	Hims & Hers Health, Inc. (HIMS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Aug-01-23 06:03AM	Phreesia Sets Release Date for Fiscal Second Quarter 2024 Results (Business Wire)
Jul-20-23 08:40PM	Analysts Say These 3 Stocks Are Their Top Picks for the Rest of 2023 (TipRanks)
Jul-14-23 04:48PM	Phreesia Acquires MediFind, Reinforcing its Commitment to Patient-Centered Care and Expanding its Offerings to Consumers (Business Wire)
Jul-13-23 04:03PM	Phreesia Names Lisa Egbuonu-Davis to its Board of Directors (Business Wire)
Jul-11-23 12:00PM	Phreesia (PHR) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Jun-13-23 06:43AM	We're Not Very Worried About Phreesia's (NYSE:PHR) Cash Burn Rate (Simply Wall St.)
May-31-23 06:30PM	Phreesia (PHR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:15PM	Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:08PM	Phreesia: Fiscal Q1 Earnings Snapshot (AP Finance)
04:03PM	Phreesia Announces First Quarter Fiscal 2024 Results (Business Wire)
May-17-23 04:03PM	Phreesia Recognized as One of Modern Healthcares "Best Places to Work in Healthcare" for a Seventh Year (Business Wire)
May-16-23 04:05PM	Phreesias Hilary Hatch Named a "Disrupter" in PM360s ELITE 100 (Business Wire)
May-15-23 05:45PM	Tivic Health Systems, Inc. (TIVC) Reports Q1 Loss, Lags Revenue Estimates (Zacks) +7.26%
May-11-23 05:35PM	Homology Medicines (FIXX) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-09-23 05:35PM	Invitae (NVTA) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -5.56% +7.68%
May-07-23 08:06AM	Why Investors Shouldn't Be Surprised By Phreesia, Inc.'s (NYSE:PHR) P/S (Simply Wall St.)
May-04-23 08:25AM	CareCloud, Inc. (CCLD) Reports Q1 Loss, Lags Revenue Estimates (Zacks)

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Linetsky David	SVP, Life Sciences	Sep 18 '24	Sale	24.09	61	1,469	8,995	Sep 19 05:49 PM
Linetsky David	SVP, Life Sciences	Sep 17 '24	Sale	24.77	36	892	9,056	Sep 19 05:49 PM
Linetsky David	Member of immediate family of	Sep 19 '24	Proposed Sale	24.04	24	577		Sep 19 04:13 PM
Linetsky David	Member of immediate family of	Sep 18 '24	Proposed Sale	24.09	61	1,469		Sep 18 03:51 PM
Linetsky David	Member of immediate family of	Sep 17 '24	Proposed Sale	24.77	36	892		Sep 17 03:38 PM
Egbuonu-Davis Lisa	Director	Sep 12 '24	Sale	23.03	1,400	32,239	18,139	Sep 13 04:06 PM
Gandhi Balaji	Chief Financial Officer	Sep 10 '24	Sale	23.25	3,502	81,422	98,578	Sep 12 06:03 PM
Hui Yvonne	Principal Accounting Officer	Sep 10 '24	Sale	23.25	744	17,298	30,019	Sep 12 06:02 PM
Indig Chaim	Chief Executive Officer	Sep 10 '24	Sale	23.25	5,295	123,110	1,223,736	Sep 12 06:00 PM
Linetsky David	SVP, Life Sciences	Sep 10 '24	Sale	23.25	1,716	39,897	203,318	Sep 12 05:58 PM
Linetsky David	SVP, Life Sciences	Sep 10 '24	Sale	23.25	95	2,209	9,092	Sep 12 05:58 PM
Roberts Evan	Chief Operating Officer	Sep 10 '24	Sale	23.25	3,148	73,192	755,719	Sep 12 05:55 PM
VanDuyn Amy Beth	SVP, Human Resources	Sep 10 '24	Sale	23.25	737	17,135	119,541	Sep 12 05:53 PM
Hoffman Allison C	General Counsel & Secretary	Sep 10 '24	Sale	23.25	2,622	60,962	123,075	Sep 12 05:51 PM
Hoffman Allison C	General Counsel & Secretary	Sep 11 '24	Sale	23.36	2,072	48,402	121,003	Sep 12 05:51 PM
Egbuonu-Davis Lisa	Director	Sep 12 '24	Proposed Sale	23.03	1,400	32,239		Sep 12 02:04 PM
Hoffman Allison C	Officer	Sep 11 '24	Proposed Sale	23.36	2,072	48,402		Sep 11 09:54 AM
Indig Chaim	Officer	Sep 10 '24	Proposed Sale	23.25	5,295	123,110		Sep 10 05:00 PM
Roberts Evan	Officer	Sep 10 '24	Proposed Sale	23.25	3,148	73,192		Sep 10 04:52 PM
VanDuyn Amy Beth	Officer	Sep 10 '24	Proposed Sale	23.25	737	17,135		Sep 10 04:48 PM
Linetsky David	Member of immediate family of	Sep 10 '24	Proposed Sale	23.25	95	2,209		Sep 10 04:48 PM
Hoffman Allison C	Officer	Sep 10 '24	Proposed Sale	23.25	2,622	60,962		Sep 10 04:38 PM
Gandhi Balaji	Officer	Sep 10 '24	Proposed Sale	23.25	3,502	81,422		Sep 10 04:32 PM
Linetsky David	Officer	Sep 10 '24	Proposed Sale	23.25	1,716	39,897		Sep 10 04:28 PM
Hui Yvonne	Officer	Sep 10 '24	Proposed Sale	23.25	744	17,298		Sep 10 04:18 PM
Hoffman Allison C	General Counsel & Secretary	Aug 26 '24	Sale	26.03	14,110	367,241	121,003	Aug 28 04:57 PM
Hoffman Allison C	Officer	Aug 26 '24	Proposed Sale	26.03	14,110	367,244		Aug 26 03:17 PM
Indig Chaim	Chief Executive Officer	Jul 29 '24	Option Exercise	2.03	7	14	1,219,368	Jul 30 05:05 PM
Indig Chaim	Chief Executive Officer	Jul 29 '24	Sale	24.75	7	173	1,219,361	Jul 30 05:05 PM
Gunzburg Janet	Officer	Jul 29 '24	Proposed Sale	24.64	202	4,977		Jul 29 03:36 PM
Indig Chaim	Officer	Jul 29 '24	Proposed Sale	24.75	7	173		Jul 29 11:12 AM
Smith Mark Douglas	Director	Jul 18 '24	Option Exercise	4.71	7,000	32,970	37,653	Jul 22 04:56 PM
Smith Mark Douglas	Director	Jul 18 '24	Sale	25.00	7,000	175,000	30,653	Jul 22 04:56 PM
Linetsky David	SVP, Life Sciences	Jul 16 '24	Sale	23.74	1,820	43,199	202,218	Jul 17 05:31 PM
Indig Chaim	Chief Executive Officer	Jul 16 '24	Sale	23.74	2,644	62,757	1,219,361	Jul 17 05:30 PM
Hui Yvonne	Principal Accounting Officer	Jul 16 '24	Sale	23.74	283	6,717	28,714	Jul 17 05:29 PM
Hoffman Allison C	General Counsel & Secretary	Jul 16 '24	Sale	23.74	800	18,988	135,113	Jul 17 05:28 PM
Gandhi Balaji	Chief Financial Officer	Jul 16 '24	Sale	23.74	783	18,585	96,447	Jul 17 05:27 PM
VanDuyn Amy Beth	SVP, Human Resources	Jul 16 '24	Sale	23.74	374	8,877	118,636	Jul 17 05:26 PM
Roberts Evan	Chief Operating Officer	Jul 16 '24	Sale	23.74	1,669	39,615	753,234	Jul 17 05:24 PM
Gunzburg Janet	Principal Accounting Officer	Jun 21 '24	Sale	20.24	114	2,307	34,820	Jun 24 04:30 PM
Linetsky David	SVP, Life Sciences	Jun 21 '24	Sale	20.24	27	546	6,953	Jun 24 04:29 PM
Linetsky David	SVP, Life Sciences	Jun 20 '24	Sale	19.73	66	1,302	6,980	Jun 21 04:35 PM
Linetsky David	SVP, Life Sciences	Jun 18 '24	Sale	19.20	41	787	7,046	Jun 21 04:35 PM
Gunzburg Janet	Principal Accounting Officer	May 01 '24	Sale	21.00	286	6,006	34,934	May 02 04:22 PM
Gunzburg Janet	Principal Accounting Officer	Apr 18 '24	Sale	22.85	912	20,836	35,220	Apr 19 04:24 PM
Linetsky David	SVP, Life Sciences	Apr 18 '24	Sale	22.85	269	6,146	7,087	Apr 19 04:24 PM
VanDuyn Amy Beth	SVP, Human Resources	Apr 15 '24	Sale	22.86	685	15,657	119,010	Apr 17 04:13 PM
Linetsky David	SVP, Life Sciences	Apr 15 '24	Sale	22.86	2,212	50,561	204,038	Apr 17 04:13 PM
Roberts Evan	Chief Operating Officer	Apr 15 '24	Sale	22.86	2,029	46,378	754,903	Apr 17 04:13 PM
Hoffman Allison C	General Counsel & Secretary	Apr 15 '24	Sale	22.86	1,238	28,297	135,621	Apr 17 04:10 PM
Gandhi Balaji	Chief Financial Officer	Apr 15 '24	Sale	22.86	948	21,669	97,230	Apr 17 04:08 PM
Indig Chaim	Chief Executive Officer	Apr 15 '24	Sale	22.86	3,392	77,532	1,222,005	Apr 17 04:07 PM
Gunzburg Janet	Principal Accounting Officer	Apr 10 '24	Sale	23.10	2,768	63,928	36,132	Apr 12 06:40 PM
Hoffman Allison C	General Counsel & Secretary	Apr 08 '24	Sale	22.62	5,549	125,519	141,485	Apr 10 05:20 PM
Hoffman Allison C	General Counsel & Secretary	Apr 09 '24	Sale	23.42	4,626	108,360	136,859	Apr 10 05:20 PM
Gandhi Balaji	Chief Financial Officer	Apr 08 '24	Sale	22.62	7,778	175,939	98,178	Apr 10 05:19 PM
Indig Chaim	Chief Executive Officer	Apr 08 '24	Sale	22.62	12,043	272,414	1,225,397	Apr 10 05:19 PM
VanDuyn Amy Beth	SVP, Human Resources	Apr 09 '24	Sale	23.43	3,768	88,277	119,695	Apr 10 05:19 PM
VanDuyn Amy Beth	SVP, Human Resources	Apr 08 '24	Sale	22.62	3,354	75,868	123,463	Apr 10 05:19 PM
Roberts Evan	Chief Operating Officer	Apr 09 '24	Option Exercise	2.03	23,330	47,360	756,932	Apr 10 05:18 PM
Roberts Evan	Chief Operating Officer	Apr 08 '24	Sale	22.62	7,178	162,367	733,602	Apr 10 05:18 PM
Linetsky David	SVP, Life Sciences	Apr 08 '24	Sale	22.62	3,914	88,535	206,250	Apr 10 05:18 PM
Linetsky David	SVP, Life Sciences	Apr 08 '24	Sale	22.62	247	5,587	7,356	Apr 10 05:18 PM
Gunzburg Janet	Principal Accounting Officer	Mar 19 '24	Sale	23.27	2,817	65,561	40,609	Apr 10 05:18 PM
Gunzburg Janet	Principal Accounting Officer	Apr 08 '24	Sale	22.62	1,709	38,658	38,900	Apr 10 05:18 PM
Gandhi Balaji	Chief Financial Officer	Mar 25 '24	Sale	23.21	3,504	81,332	94,030	Mar 27 04:06 PM
Roberts Evan	Chief Operating Officer	Mar 21 '24	Sale	23.52	25,962	610,684	728,570	Mar 25 04:16 PM
Gunzburg Janet	Principal Accounting Officer	Mar 20 '24	Sale	23.66	137	3,241	38,949	Mar 21 04:11 PM
Linetsky David	SVP, Life Sciences	Mar 20 '24	Sale	23.66	30	710	7,095	Mar 21 04:11 PM
Linetsky David	SVP, Life Sciences	Mar 19 '24	Sale	23.27	402	9,356	7,125	Mar 20 04:21 PM
Linetsky David	SVP, Life Sciences	Mar 18 '24	Sale	22.22	46	1,022	7,527	Mar 20 04:21 PM
Gunzburg Janet	Principal Accounting Officer	Feb 09 '24	Sale	28.00	480	13,440	39,086	Feb 13 04:58 PM
Gunzburg Janet	Principal Accounting Officer	Feb 02 '24	Sale	27.00	480	12,960	39,566	Feb 06 04:22 PM
Gunzburg Janet	Principal Accounting Officer	Feb 01 '24	Sale	25.99	328	8,525	40,046	Feb 02 06:06 PM
Gunzburg Janet	Principal Accounting Officer	Jan 12 '24	Sale	24.11	205	4,943	40,374	Feb 02 06:06 PM
Gandhi Balaji	Chief Financial Officer	Jan 17 '24	Sale	24.12	9,192	221,726	97,534	Jan 18 04:53 PM
Gandhi Balaji	Chief Financial Officer	Jan 16 '24	Sale	24.55	932	22,876	106,726	Jan 18 04:53 PM
VanDuyn Amy Beth	SVP, Human Resources	Jan 17 '24	Sale	24.12	10,213	246,354	119,695	Jan 18 04:53 PM
VanDuyn Amy Beth	SVP, Human Resources	Jan 16 '24	Sale	24.55	738	18,115	129,908	Jan 18 04:53 PM
Davidoff Michael J.	SVP, Payer Business	Jan 17 '24	Sale	24.12	17,677	426,398	73,391	Jan 18 04:53 PM
Davidoff Michael J.	SVP, Payer Business	Jan 16 '24	Sale	24.55	1,310	32,155	91,068	Jan 18 04:53 PM
Linetsky David	SVP, Life Sciences	Jan 17 '24	Sale	24.12	30,659	739,544	204,059	Jan 18 04:52 PM
Linetsky David	SVP, Life Sciences	Jan 16 '24	Sale	24.55	2,318	56,896	234,718	Jan 18 04:52 PM
Hoffman Allison C	General Counsel & Secretary	Jan 17 '24	Sale	24.12	7,605	183,445	136,859	Jan 18 04:52 PM
Hoffman Allison C	General Counsel & Secretary	Jan 16 '24	Sale	24.55	1,316	32,302	144,464	Jan 18 04:52 PM
Roberts Evan	Chief Operating Officer	Jan 17 '24	Sale	24.12	41,081	990,939	754,532	Jan 18 04:52 PM
Roberts Evan	Chief Operating Officer	Jan 16 '24	Sale	24.55	2,247	55,154	795,613	Jan 18 04:52 PM
Indig Chaim	Chief Executive Officer	Jan 17 '24	Sale	24.12	63,931	1,542,118	1,216,479	Jan 18 04:51 PM
Indig Chaim	Chief Executive Officer	Jan 16 '24	Sale	24.55	3,586	88,020	1,280,410	Jan 18 04:51 PM
Gunzburg Janet	Principal Accounting Officer	Dec 19 '23	Sale	23.72	118	2,799	40,579	Dec 20 04:14 PM
Linetsky David	SVP, Life Sciences	Dec 18 '23	Sale	23.15	234	5,418	7,598	Dec 20 04:13 PM
Linetsky David	SVP, Life Sciences	Dec 19 '23	Sale	23.72	25	593	7,573	Dec 20 04:13 PM
Gunzburg Janet	Principal Accounting Officer	Nov 01 '23	Sale	13.38	298	3,988	40,697	Nov 02 04:39 PM
Roberts Evan	Chief Operating Officer	Oct 31 '23	Option Exercise	2.03	30,000	60,900	775,860	Nov 02 04:36 PM
Davidoff Michael J.	SVP, Payer Business	Oct 16 '23	Sale	16.61	1,198	19,898	92,378	Oct 17 06:22 PM
Gandhi Balaji	Chief Financial Officer	Oct 16 '23	Sale	16.61	861	14,300	85,658	Oct 17 06:19 PM
VanDuyn Amy Beth	SVP, Human Resources	Oct 16 '23	Sale	16.61	665	11,045	118,146	Oct 17 06:17 PM
Hoffman Allison C	General Counsel & Secretary	Oct 16 '23	Sale	16.61	1,297	21,542	115,025	Oct 17 06:15 PM
Roberts Evan	Chief Operating Officer	Oct 16 '23	Sale	16.61	1,971	32,736	745,860	Oct 17 06:14 PM

Open in Screener

JAZZ

Jazz Pharmaceuticals plc

Sep 20 • 04:00PM ET

110.76

Dollar change -0.53
Percentage change -0.48	%

Healthcare • Biotechnology • Ireland • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

JAZZ Jazz Pharmaceuticals plc daily Stock Chart

Held by: COWZ IJH VTI VB VBR VXF MDY FXH SPMD VHT

Index	-	P/E	19.79	EPS (ttm)	5.60	Insider Own	3.49%	Shs Outstand	62.26M	Perf Week	1.81%
Market Cap	6.84B	Forward P/E	5.14	EPS next Y	21.55	Insider Trans	-0.30%	Shs Float	59.60M	Perf Month	-3.15%
Income	394.92M	PEG	4.08	EPS next Q	5.52	Inst Own	94.82%	Short Float	3.17%	Perf Quarter	2.58%
Sales	3.91B	P/S	1.75	EPS this Y	6.74%	Inst Trans	-0.78%	Short Ratio	2.70	Perf Half Y	-10.75%
Book/sh	60.94	P/B	1.82	EPS next Y	10.38%	ROA	3.49%	Short Interest	1.89M	Perf Year	-17.18%
Cash/sh	32.08	P/C	3.45	EPS next 5Y	4.85%	ROE	10.84%	52W Range	99.06 - 137.38	Perf YTD	-9.95%
Dividend Est.	-	P/FCF	6.55	EPS past 5Y	-3.53%	ROI	4.42%	52W High	-19.38%	Beta	0.57
Dividend TTM	-	Quick Ratio	1.90	Sales past 5Y	15.52%	Gross Margin	73.60%	52W Low	11.81%	ATR (14)	2.66
Dividend Ex-Date	-	Current Ratio	2.25	EPS Y/Y TTM	546.69%	Oper. Margin	16.63%	RSI (14)	51.46	Volatility	2.28% 2.20%
Employees	2800	Debt/Eq	1.54	Sales Y/Y TTM	3.91%	Profit Margin	10.10%	Recom	1.42	Target Price	178.29
Option/Short	Yes / Yes	LT Debt/Eq	1.37	EPS Q/Q	70.48%	Payout	0.00%	Rel Volume	2.79	Prev Close	111.29
Sales Surprise	1.37%	EPS Surprise	7.68%	Sales Q/Q	6.95%	Earnings	Jul 31 AMC	Avg Volume	700.63K	Price	110.76
SMA20	0.01%	SMA50	0.25%	SMA200	-3.50%	Trades		Volume	1,957,057	Change	-0.48%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-05-24	Initiated	Goldman	Buy	$169
Jan-03-24	Initiated	Robert W. Baird	Outperform	$160
Nov-27-23	Downgrade	UBS	Buy → Neutral	$170 → $135
Sep-29-23	Initiated	Raymond James	Mkt Perform
Jun-12-23	Resumed	Wells Fargo	Equal Weight	$184 → $140
Dec-09-22	Upgrade	Goldman	Neutral → Buy	$192 → $190
Jun-14-22	Initiated	UBS	Buy	$194
Apr-06-22	Downgrade	Goldman	Buy → Neutral	$202 → $196
Nov-19-21	Resumed	Goldman	Buy	$198
Oct-07-21	Resumed	Jefferies	Buy	$172
Oct-05-21	Initiated	Citigroup	Buy	$200
Sep-23-21	Initiated	Needham	Buy	$220
May-19-21	Resumed	JP Morgan	Overweight	$183 → $206
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$186
Feb-05-21	Reiterated	H.C. Wainwright	Buy	$195 → $207
Feb-03-21	Upgrade	Piper Sandler	Neutral → Overweight	$150 → $175
Jan-29-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Dec-16-20	Initiated	UBS	Buy	$174
Nov-03-20	Reiterated	H.C. Wainwright	Buy	$185 → $195
Oct-09-20	Reiterated	H.C. Wainwright	Buy	$175 → $185

Show Previous Ratings

Sep-16-24 07:30AM	Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024 (PR Newswire)
Sep-09-24 07:58AM	Jazz Pharmaceuticals to Present Advancements in Solid Tumor Oncology Research at ESMO 2024 (PR Newswire)
Sep-07-24 10:17PM	Jazz Pharmaceuticals plc (JAZZ): Why Do Hedge Funds Recommend This Biotech Stock? (Insider Monkey)
Sep-05-24 07:30AM	Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex/Epidyolex (cannabidiol) at the European Epilepsy Congress 2024 (PR Newswire)
01:07AM	Jazz Pharmaceuticals plc (JAZZ): Among the Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
12:12AM	Loading…
Sep-04-24 12:12AM	Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases (PR Newswire)
Sep-03-24 07:00AM	Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases (PR Newswire) -5.74%
Sep-02-24 06:05PM	10 Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
Aug-30-24 11:31AM	Why Is Jazz (JAZZ) Up 1.1% Since Last Earnings Report? (Zacks)
01:16AM	Jazz Pharmaceuticals plc (JAZZ): Top ADR Stock According to Hedge Funds (Insider Monkey)
Aug-23-24 10:13AM	Jazzs cannabidiol therapy flunks in Japanese Phase III trial (Pharmaceutical Technology)
Aug-22-24 04:05PM	Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies (PR Newswire)
Aug-21-24 04:15PM	Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences (PR Newswire)
Aug-06-24 09:55AM	Wall Street Analysts Believe Jazz (JAZZ) Could Rally 56.66%: Here's is How to Trade (Zacks)
09:40AM	Is Jazz Pharmaceuticals (JAZZ) a Great Value Stock Right Now? (Zacks)
04:06PM	Loading…
Aug-05-24 04:06PM	The 3 Best Cannabis Stocks to Buy in August 2024 (InvestorPlace)
09:15AM	Investing in Jazz (JAZZ)? Don't Miss Assessing Its International Revenue Trends (Zacks)
Jul-31-24 10:36PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
05:45PM	Jazz Pharmaceuticals (JAZZ) Beats Q2 Earnings and Revenue Estimates (Zacks)
04:40PM	Jazz: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance (PR Newswire)
Jul-29-24 06:00AM	3 Biotech Stocks to Buy on the Dip: July 2024 (InvestorPlace)
Jul-25-24 04:05PM	Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting (PR Newswire)
Jul-24-24 10:01AM	Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-23-24 03:52AM	Nanotechnology in medicine: Who are the leading public companies? (Medical Device Network)
Jul-22-24 07:45AM	Jazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes due 2026 (PR Newswire)
Jul-19-24 01:58PM	If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names (InvestorPlace)
Jul-17-24 04:15PM	Jazz Pharmaceuticals to Report 2024 Second Quarter Financial Results on July 31, 2024 (PR Newswire)
Jul-11-24 08:30AM	Is The Options Market Predicting A Spike In JAZZ Pharmaceuticals (JAZZ) Stock? (Zacks)
Jul-09-24 07:45AM	Jazz Pharmaceuticals Promotes Samantha Pearce to Chief Commercial Officer (PR Newswire)
08:09AM	Loading…
Jul-04-24 08:09AM	3 Mid-Cap Growth Rockets Trading at Deep Discounts to Their Potential (InvestorPlace)
Jul-01-24 12:16AM	Is Jazz Pharmaceuticals plc (JAZZ) the Best Pot Stock to Buy Now? (Insider Monkey)
Jun-26-24 02:11PM	7 Biotech Stocks to Boost Your Portfolio to Peak Health (InvestorPlace)
Jun-25-24 03:39PM	3 Cannabis Stocks That Could Make Your Grandchildren Rich (InvestorPlace)
Jun-21-24 07:00AM	Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs (BioPharma Dive)
06:33AM	Jazz Pharmaceuticals essential tremor drug falls flat in Phase IIb trial (Clinical Trials Arena)
Jun-20-24 04:08PM	Jazz Dives But Key Rival Praxis Surges On Essential Tremor Drug Failure (Investor's Business Daily)
10:08AM	Jazz Dives And Takes Praxis With It On Essential Tremor Drug Failure (Investor's Business Daily)
07:45AM	Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor (PR Newswire)
Jun-14-24 06:13AM	3 Blue-Chip Stocks to Triple Your Wealth by 2026: June Edition (InvestorPlace)
Jun-11-24 10:42AM	Load Up, Says Goldman Sachs About These 2 Strong Buy Stocks (TipRanks)
Jun-03-24 02:27PM	7 Overlooked Stocks Offering Long-Term Stability From the Shadows (InvestorPlace)
Jun-01-24 08:05AM	Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 (PR Newswire)
May-31-24 11:31AM	Why Is Jazz (JAZZ) Down 3.5% Since Last Earnings Report? (Zacks)
May-30-24 07:30AM	Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024 (PR Newswire)
May-29-24 04:15PM	Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences (PR Newswire)
07:45AM	Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer (PR Newswire)
May-28-24 07:00AM	NodThera Announces Appointment of Daniel Swisher as Chief Executive Officer (GlobeNewswire)
May-26-24 10:09AM	3 Cannabis Stocks to Buy Now: May 2024 (InvestorPlace)
May-23-24 06:00AM	7 Blue-Chip Stocks to Buy Now: May 2024 (InvestorPlace)
May-22-24 07:01PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
04:00PM	Jazz Pharmaceuticals Announces Collaboration With Life Science Cares To Improve the Wellbeing of Under Resourced Communities Through Employee Volunteerism (ACCESSWIRE)
May-17-24 02:32PM	3 Cheap Blue-Chip Stocks to Buy Now: May 2024 (InvestorPlace)
May-09-24 09:19AM	7 Cannabis Stocks to Buy for a Smoking-Hot 2024 (InvestorPlace)
May-08-24 04:30PM	The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy? (InvestorPlace)
01:22PM	Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-07-24 05:37PM	Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing (MT Newswires)
10:57AM	Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-06-24 09:29AM	Jazz (JAZZ) International Revenue Performance Explored (Zacks)
May-03-24 12:41PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
11:49AM	UBS Adjusts Price Target on Jazz Pharmaceuticals to $117 From $121, Maintains Neutral Rating (MT Newswires)
May-02-24 11:26AM	Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates (Zacks)
03:53AM	Jazz Pharmaceuticals Q1 Adjusted Earnings Decline, Revenue Rises; Reaffirms 2024 Outlook (MT Newswires)
May-01-24 08:56PM	JAZZ Stock Earnings: Jazz Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:00PM	Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
04:24PM	Jazz: Q1 Earnings Snapshot (Associated Press Finance)
04:10PM	Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference (PR Newswire)
04:05PM	Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance (PR Newswire)
Apr-30-24 09:50AM	Jazz Pharmaceuticals Focuses on Taking Actions To Positively Impact the Planet This Earth Month (ACCESSWIRE)
Apr-24-24 04:05PM	Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024 (PR Newswire)
10:01AM	Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
05:21AM	3 No-Brainer Stocks to Buy With $300 Right Now (Motley Fool)
Apr-23-24 11:15AM	Jazz Pharmaceuticals Employees Wear Purple To Support Epilepsy Awareness and Community (ACCESSWIRE)
Apr-17-24 04:15PM	Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024 (PR Newswire)
Apr-10-24 07:45AM	Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting (PR Newswire)
Apr-04-24 09:15AM	Following the Money Trail: Where are Hedge Funds Investing? (Insider Monkey)
Apr-02-24 07:30AM	Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer (PR Newswire)
Mar-29-24 11:30AM	Why Is Jazz (JAZZ) Up 1.3% Since Last Earnings Report? (Zacks)
Mar-28-24 10:15AM	Cancer and the Combination Approach (ACCESSWIRE)
Mar-20-24 10:15AM	Jazz Pharmaceuticals Celebrates International Womens Day (ACCESSWIRE)
Mar-18-24 03:28PM	20 States with the Cheapest Weed in America (Insider Monkey)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-14-24 12:00PM	Exploring How Jazz Pharmaceuticals Honored U.S. Black History Month (ACCESSWIRE)
10:00AM	Unlocking Jazz Pharmaceuticals' Potential: A Roadmap for Growth (GuruFocus.com)
Mar-13-24 02:25PM	7 Biotech Stocks to Buy as Sector Rotation Ramps Up (InvestorPlace)
Mar-12-24 05:34PM	11 Stocks Insiders are Buying Now (Insider Monkey)
04:15PM	Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024 (PR Newswire)
Mar-09-24 11:15AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Mar-07-24 01:51PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
01:10PM	Q4 2023 Zymeworks Inc Earnings Call (Thomson Reuters StreetEvents)
10:08AM	10 Mid-Cap Stocks with Insider Purchases (Insider Monkey)
Feb-29-24 10:45AM	Jazz (JAZZ) Q3 Earnings Lag, Revenues in Line With Estimates (Zacks) -8.33%
10:35AM	Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 06:30PM	Here's What Key Metrics Tell Us About Jazz (JAZZ) Q4 Earnings (Zacks)
05:20PM	Jazz Pharmaceuticals (JAZZ) Q4 Earnings Lag Estimates (Zacks)
04:33PM	Jazz Pharmaceuticals PLC (JAZZ) Reports Strong Revenue Growth and Robust Pipeline Progress (GuruFocus.com)
04:29PM	Jazz: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance (PR Newswire)
Feb-27-24 10:15PM	Q4 2023 Ligand Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
07:45AM	Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors (PR Newswire)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Henderson Mary Elizabeth	SVP, Technical Operations	Sep 06 '24	Sale	108.30	1,410	152,703	14,531	Sep 11 11:38 AM
Henderson Mary Elizabeth	Officer	Sep 06 '24	Proposed Sale	110.00	2,691	296,010		Sep 05 07:50 PM
Winningham Rick E	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:57 PM
Smith Mark Douglas	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:55 PM
RIEDEL NORBERT G	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:49 PM
ORiordan Anne	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:42 PM
O'Keefe Kenneth W	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:35 PM
McSharry Heather Ann	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:29 PM
Cook Jennifer E.	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:19 PM
Sohn Catherine A.	Director	Aug 05 '24	Proposed Sale	111.00	3,075	341,325		Aug 02 04:20 PM
Carr Patricia	SVP, Chief Accounting Officer	Jun 07 '24	Sale	108.83	163	17,738	6,596	Jun 11 08:15 PM
Patil Neena M	EVP & Chief Legal Officer	May 03 '24	Sale	109.65	5,000	548,250	36,629	May 07 05:31 PM
Carr Patricia	SVP, Chief Accounting Officer	Mar 06 '24	Sale	119.64	1,936	231,628	8,364	Mar 08 06:07 PM
Carr Patricia	SVP, Chief Accounting Officer	Mar 07 '24	Sale	116.98	1,768	206,821	6,596	Mar 08 06:07 PM
Johnson Philip L	EVP & Chief Financial Officer	Mar 01 '24	Buy	119.65	12,000	1,435,800	27,932	Mar 05 07:28 PM
Smith Mark Douglas	Director	Dec 04 '23	Sale	119.27	417	49,736	6,888	Dec 06 04:39 PM
Cook Jennifer E.	Director	Dec 04 '23	Sale	119.27	417	49,736	6,888	Dec 06 04:31 PM

TDOC

Teladoc Health Inc

PHR

Phreesia Inc

JAZZ

Jazz Pharmaceuticals plc

Upgrade your FINVIZ experience